Kaken Pharmaceutical

This early-stage study tested how a single dose of an investigational drug, KP-001, is processed by the body in people with different levels of liver impairment compared to healthy people. The goal was to understand if liver problems change how the drug works or its safety. The s…

This study aimed to understand how an experimental drug called KP-001 might interact with other common substances in the body. Researchers gave KP-001 to 38 healthy volunteers along with a cholesterol medication (rosuvastatin) and caffeine to see if it changed how these substance…

This study aimed to see if an experimental drug called KP-001 affects the electrical rhythm of the heart. It involved 40 healthy adult volunteers who received different doses of KP-001, a placebo (inactive substance), and a comparison drug. The main goal was to measure the drug's…